<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="OriginalFile" content="140095-1 .docx" />
<meta name="generator" content="Adobe RoboHelp 2019" />
<title>40:962.1.1</title>
<link rel="stylesheet" href="../statute3.css" type="text/css" />
<script type="text/javascript" language="JavaScript">
//<![CDATA[
function reDo() {
  if (innerWidth != origWidth || innerHeight != origHeight)
     location.reload();
}
if ((parseInt(navigator.appVersion) == 4) && (navigator.appName == "Netscape")) {
        origWidth = innerWidth;
        origHeight = innerHeight;
        onresize = reDo;
}
onerror = null; 
//]]>
</script>
<style type="text/css">
/*<![CDATA[*/
<!--
div.WebHelpPopupMenu { position:absolute;
left:0px;
top:0px;
z-index:4;
visibility:hidden; }
-->
/*]]>*/
</style>

<script type="text/javascript" language="javascript1.2" src="../whmsg.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript" src="../whver.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whutils.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whproxy.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whlang.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whtopic.js" charset="utf-8">
</script>
</head>
<body style="word-wrap: break-word; text-justify-trim: punctuation;">
<script type="text/javascript" language="javascript1.2">
//<![CDATA[
<!--
if (window.gbWhTopic)
{
        var strUrl = decodeURI(document.location.href);
        var bc = 0;
        var n = strUrl.toLowerCase().indexOf("bc-");
        if(n != -1)
        {
                document.location.replace(strUrl.substring(0, n));
                bc = strUrl.substring(n+3);
        }

        if (window.addTocInfo)
        {
        addTocInfo("Caddo Parish School Board\nStatutes\nTitle 40\n40:962.1.1");

        }
        if (window.writeBtnStyle)
                writeBtnStyle();

        if (window.writeIntopicBar)
                writeIntopicBar(0);

        
        
}
else
        if (window.gbIE4)
                document.location.reload();

onLoadHandler = function()
{
  if (window.setRelStartPage)
        {
        setTimeout("setRelStartPage('../CaddoCAPS.htm');", 1)

    setTimeout("UpdateBreadCrumbsMarker();", 1);
        }
}

if (window.addEventListener){  
        window.addEventListener('load', onLoadHandler, false);   
} else if (window.attachEvent){  
        window.attachEvent('onload', onLoadHandler);  
}

function onSetStartPage()
{
  autoSync(0);
  sendSyncInfo();
  sendAveInfoOut();
}
//-->
//]]>
</script><script type="text/javascript" src="../ehlpdhtm.js" language="JavaScript1.2">
</script>
<p class="PdfParaStyle01"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Title 40. Public Health and Safety</font></span></p>
<p class="PdfParaStyle01"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Chapter 4. Food and Drugs</font></span></p>
<p class="PdfParaStyle01"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Part X. Uniform Controlled Dangerous Substances Law</font></span></p>
&#160;
<p style="margin-bottom: 0in; line-height: normal; text-autospace: none;">&#160;</p>
<p class="PdfParaStyle04"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #252525;"><font size="2" color="#252525" style="font-size:10.000000pt;">40:962.1.1&#160;&#160;&#160;Possession of twelve grams or more of ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">A. (1) It is unlawful for any person to possess twelve grams or more of ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, or salts of optical isomers.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(2) It is unlawful for any person to possess ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, or salts of optical isomers in powder form unless the weight of the ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, or salts of optical isomers is less than twelve grams and the powder is in the manufacturerâ€™s original packaging and may be lawfully sold over the counter without a prescription under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301 et seq.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">B. The provisions of this Section shall not apply to any of the following:&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(1) Any person possessing a valid prescription for ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(2) Any licensed manufacturer, wholesaler, or distributor who sells, transfers, or otherwise furnishes ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers to any licensed practitioner operating within the course and scope of that profession.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(3) Any licensed pharmacist or other authorized person who sells or furnishes ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers in the course of their professional practice, pursuant to the prescription of any licensed practitioner.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(4) Any licensed practitioner who administers or furnishes ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers in the course of their professional practice.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(5) Any person in possession of ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers in his residence under circumstances that are consistent with typical medicinal or household use. Factors that the court may consider in determining whether the circumstances of the possession are consistent with typical medicinal or household use include but are not limited to storage location, purchase date, expiration date, possession of the products in a variety of strengths, brands, types, or purposes and the health conditions of persons in the residence.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(6) Any manufacturer, wholesaler, distributor, or retail business which sells, transfers, or otherwise furnishes products to customers for medicinal purposes, which products contain ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers, while acting within the scope and course of that business.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">C. The provisions of this Section shall not apply to any pediatric products primarily intended for administration, according to label instructions, to children under twelve years of age provided that:&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(1) For any solid dosage form, the individual dosage unit, according to label instructions, does not exceed fifteen milligrams of ephedrine, pseudoephedrine, or phenylpropanolamine.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(2) For any liquid dosage form, the recommended dosage units, according to label instructions, does not exceed fifteen milligrams of ephedrine, pseudoephedrine, or phenylpropanolamine per five milliliters of the liquid product.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(3) For any liquid dosage form intended for administration to children under two years of age, the recommended dosage does not exceed two milliliters and the total package content is not more than one fluid ounce.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">D. <i>Repealed by Acts 2009, No. 314, Â§ 2.</i>&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">E. Whoever violates any provision of this Section shall be fined not more than two thousand dollars or imprisoned, with or without hard labor, for not more than two years, or both.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">F. Notwithstanding any provision of law to the contrary, unless listed in another schedule, any product that contains any detectable quantity of ephedrine, pseudoephedrine, or phenylpropanolamine, their salts or optical isomers, or salts of optical isomers is a Schedule V controlled dangerous substance and shall be dispensed, sold, or distributed only in accordance with the provisions of R.S. 40:1049.1 et seq. Such products shall be exempt from the reporting for Schedule V drugs as provided for in R.S. 40:1001 et seq.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p class="PdfParaStyle10"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Added by Acts 2003, No. 1000, Â§ 1. Amended by Acts 2004, No. 656, Â§ 1; Acts 2009, No. 314, Â§ 1; Acts 2018, No. 206, Â§ 4.</font></span></p>
<script type="text/javascript" language="javascript1.2">
//<![CDATA[
<!--
if (window.writeIntopicBar)
        writeIntopicBar(0);


highlightSearch();
//-->
//]]>
</script>
</body>
</html>
